Reliable, high-throughput measurement of critical biomarkers using ELISA (enzyme-linked immunosorbent assays).
ELISAs are a solid-phase immunoassay that use enzyme-linked antibodies to detect the analyte of interest. ELISAs are particularly useful for studies measuring a limited set of biomarkers and are often combined with assays such as ELISpot and flow cytometry.
At CellCarta, we’ve optimized our ELISA services for preclinical and clinical applications. For any regulatory requirements your program must meet, our scientific team is equipped to handle even the most demanding assay challenges.
ELISAs are a benchmark technology widely accepted by researchers, regulators, and clinicians worldwide.
Programs that depend on consistent, reproducible data will benefit from our established track record implementing ELISA services across preclinical and clinical settings.
ELISAs deliver robust and reliable data over a large dynamic range. This sensitivity supports accurate quantification of target proteins at low concentrations, giving programs the precision required for measuring critical biomarkers and therapeutic efficacy assessment.
Our single-analyte ELISA assays can be adapted to meet your study’s specifications. We offer off-the-shelf (OTS) assays that enable rapid implementation into your clinical trial.
When your study requires more, custom ELISA assays may also be developed and validated for your program’s scientific and regulatory requirements at any stage of development.
Reduced optimization time and rapid turnaround make ELISA well-suited for programs requiring efficient monitoring across large sample sets. Its high-throughput capacity supports timely data delivery without compromising the reliability or precision of biomarker measurement.
ELISAs are a benchmark technology widely accepted by researchers, regulators, and clinicians worldwide.
Programs that depend on consistent, reproducible data will benefit from our established track record implementing ELISA services across preclinical and clinical settings.
ELISAs deliver robust and reliable data over a large dynamic range. This sensitivity supports accurate quantification of target proteins at low concentrations, giving programs the precision required for measuring critical biomarkers and therapeutic efficacy assessment.
Our single-analyte ELISA assays can be adapted to meet your study’s specifications. We offer off-the-shelf (OTS) assays that enable rapid implementation into your clinical trial.
When your study requires more, custom ELISA assays may also be developed and validated for your program’s scientific and regulatory requirements at any stage of development.
Reduced optimization time and rapid turnaround make ELISA well-suited for programs requiring efficient monitoring across large sample sets. Its high-throughput capacity supports timely data delivery without compromising the reliability or precision of biomarker measurement.
When a program requires deeper immune profiling, ELISA services are routinely combined with cellular assays such as ELISpot or flow cytometry. CellCarta offers a full range of clinical biomarker services, so your data requirements are addressed within a single, integrated program.
Expert optimization and validation of ELISA assays for preclinical and clinical programs.
High-Throughput Capabilities
Adaptable Platform
Benchmark Technology
Vast Assay Portfolio
Regulatory Ready
ELISA services are part of CellCarta’s full immunoassay portfolio. Explore related offerings to address the full scope of your biomarker program.
Qualitative and quantitative single-cell immune profiling using multiparametric platforms.
Measure up to ten analytes in each plate well using serum or plasma samples as small as 25 μL.
Characterize single-cell cytokine secretion with validated ELISpot and FluoroSpot assays.
ELISA, or enzyme-linked immunosorbent assay, is a solid-phase immunoassay that uses enzyme-linked antibodies to detect an analyte of interest. Antibodies directed against the target protein bind to the target ligand, and the enzyme-linked detection system generates a measurable signal that can be quantified. ELISAs are a well-established, widely accepted method for biomarker measurement.
ELISA services are well-suited for programs requiring focused measurement of a limited set of biomarkers. They are commonly used when robust, reproducible single-analyte data is needed and are often combined with other cellular assays, including ELISpot and flow cytometry, when broader immune profiling is required.
CellCarta has proficiency in numerous immunoassays that are selected based on your program’s specifications. If your program requires multiplexing or multi-analyte detection, platforms such as Olink™, Ella™, and MSD® may be implemented instead. Consult with our team to discover the right workflow for your study.
CellCarta’s ELISA services are available at and can be validated to all regulatory requirements. The appropriate compliance tier is determined by the stage and requirements of your program. CellCarta’s scientific team will work with you to define the right approach for your specific assay and program goals.
